Biagio Pinchera

1.9k total citations
72 papers, 785 citations indexed

About

Biagio Pinchera is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Biagio Pinchera has authored 72 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 28 papers in Epidemiology and 18 papers in Hepatology. Recurrent topics in Biagio Pinchera's work include COVID-19 Clinical Research Studies (27 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Liver Disease Diagnosis and Treatment (14 papers). Biagio Pinchera is often cited by papers focused on COVID-19 Clinical Research Studies (27 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Liver Disease Diagnosis and Treatment (14 papers). Biagio Pinchera collaborates with scholars based in Italy, United States and France. Biagio Pinchera's co-authors include Ivan Gentile, Riccardo Scotto, Antonio Riccardo Buonomo, Emanuela Zappulo, Giuseppe Castaldo, Nicola Schiano Moriello, Guglielmo Borgia, Gabriella Fabbrocini, Monica Gelzo and Sara Cacciapuoti and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Life Sciences.

In The Last Decade

Biagio Pinchera

69 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Biagio Pinchera Italy 18 345 287 163 135 127 72 785
Riccardo Scotto Italy 22 359 1.0× 393 1.4× 219 1.3× 233 1.7× 97 0.8× 86 1.3k
Francisco Carmona-Torre Spain 14 169 0.5× 214 0.7× 182 1.1× 78 0.6× 55 0.4× 46 635
Yilan Zeng China 10 278 0.8× 174 0.6× 83 0.5× 161 1.2× 92 0.7× 36 539
Mahmoud Nassar United States 16 289 0.8× 207 0.7× 45 0.3× 63 0.5× 115 0.9× 115 888
Serena Ludovisi Italy 14 334 1.0× 217 0.8× 265 1.6× 63 0.5× 146 1.1× 20 964
Kenneth J. Wilkins United States 19 188 0.5× 239 0.8× 89 0.5× 242 1.8× 45 0.4× 46 1.0k
Jen-Tse Cheng United States 14 321 0.9× 152 0.5× 117 0.7× 246 1.8× 46 0.4× 28 1.0k
Zhi Jiang China 15 133 0.4× 133 0.5× 63 0.4× 176 1.3× 46 0.4× 47 680
Zhilin Zeng China 16 240 0.7× 261 0.9× 29 0.2× 181 1.3× 69 0.5× 28 959
Zhanju Liu China 11 595 1.7× 244 0.9× 47 0.3× 160 1.2× 284 2.2× 26 1.3k

Countries citing papers authored by Biagio Pinchera

Since Specialization
Citations

This map shows the geographic impact of Biagio Pinchera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biagio Pinchera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biagio Pinchera more than expected).

Fields of papers citing papers by Biagio Pinchera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biagio Pinchera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biagio Pinchera. The network helps show where Biagio Pinchera may publish in the future.

Co-authorship network of co-authors of Biagio Pinchera

This figure shows the co-authorship network connecting the top 25 collaborators of Biagio Pinchera. A scholar is included among the top collaborators of Biagio Pinchera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biagio Pinchera. Biagio Pinchera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aveta, Achille, Giorgio Napodano, Gianluca Spena, et al.. (2025). Rare case of urinary tract infection caused by Cedecea lapagei in a 93-year-old patient in southern Italy. Infezioni in Medicina. 33(2). 221–225. 1 indexed citations
2.
Pinchera, Biagio, et al.. (2024). Alzheimer's disease and herpes viruses: Current events and perspectives. Reviews in Medical Virology. 34(3). e2550–e2550. 5 indexed citations
3.
Bologna, Eugenio, Leslie Claire Licari, Celeste Manfredi, et al.. (2024). Carbapenem-Resistant Enterobacteriaceae in Urinary Tract Infections: From Biological Insights to Emerging Therapeutic Alternatives. Medicina. 60(2). 214–214. 10 indexed citations
4.
5.
Gelzo, Monica, Filippo Scialò, Sara Cacciapuoti, et al.. (2022). Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves?. Viruses. 14(3). 534–534. 12 indexed citations
6.
Scalia, Giulia, Maddalena Raia, Monica Gelzo, et al.. (2022). Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection. Journal of Clinical Medicine. 11(15). 4306–4306. 7 indexed citations
7.
Viceconte, Giulio, Andrea Ponsiglione, Antonio Riccardo Buonomo, et al.. (2022). COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study. Infezioni in Medicina. 30(4). 555–562. 2 indexed citations
8.
Terracciano, Daniela, Biagio Pinchera, Valéria Valente, et al.. (2022). Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status. Frontiers in Medicine. 9. 1034288–1034288. 15 indexed citations
9.
10.
Napolitano, Filomena, Gaetano Di Spigna, Maria Vargas, et al.. (2021). Soluble Urokinase Receptor as a Promising Marker for Early Prediction of Outcome in COVID-19 Hospitalized Patients. Journal of Clinical Medicine. 10(21). 4914–4914. 16 indexed citations
11.
Scotto, Riccardo, Biagio Pinchera, Francesco Perna, et al.. (2021). Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia. International Journal of Environmental Research and Public Health. 18(4). 2078–2078. 25 indexed citations
12.
Gelzo, Monica, Sara Cacciapuoti, Biagio Pinchera, et al.. (2021). Further Findings Concerning Endothelial Damage in COVID-19 Patients. Biomolecules. 11(9). 1368–1368. 9 indexed citations
13.
14.
Gelzo, Monica, Sara Cacciapuoti, Biagio Pinchera, et al.. (2021). Prognostic Role of Neutrophil to Lymphocyte Ratio in COVID-19 Patients: Still Valid in Patients That Had Started Therapy?. Frontiers in Public Health. 9. 664108–664108. 21 indexed citations
15.
Patrì, Angela, Biagio Pinchera, Lorenzo Spirito, et al.. (2020). Gastrointestinal tract diseases as a risk factor for SARSCoV2 rectal shedding? An Italian report on 10 COVID-19 patients. Intestinal Research. 19(3). 354–356. 5 indexed citations
16.
Petrosillo, Nicola, et al.. (2019). Preventing sepsis development in complicated urinary tract infections. Expert Review of Anti-infective Therapy. 18(1). 47–61. 17 indexed citations
17.
Coppola, Nicola, Federica Portunato, Antonio Riccardo Buonomo, et al.. (2019). Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection. Journal of Nephrology. 32(5). 763–773. 21 indexed citations
18.
Scotto, Riccardo, Antonio Riccardo Buonomo, Nicola Schiano Moriello, et al.. (2019). Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus Infection. Reviews on Recent Clinical Trials. 14(3). 173–182. 31 indexed citations
19.
Gentile, Ivan, Biagio Pinchera, Giulio Viceconte, et al.. (2019). Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study.. PubMed. 27(1). 32–39. 3 indexed citations
20.
Buonomo, Antonio Riccardo, Riccardo Scotto, Biagio Pinchera, et al.. (2018). Epidemiology and risk factors for hepatitis C virus genotypes in a high prevalence region in Italy.. PubMed. 41(1). 26–29. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Riccardo Scotto Breakdown of academic impact, for papers by Francisco Carmona-Torre Breakdown of academic impact, for papers by Yilan Zeng Breakdown of academic impact, for papers by Mahmoud Nassar Breakdown of academic impact, for papers by Serena Ludovisi Breakdown of academic impact, for papers by Kenneth J. Wilkins Breakdown of academic impact, for papers by Jen-Tse Cheng Breakdown of academic impact, for papers by Zhi Jiang Breakdown of academic impact, for papers by Zhilin Zeng Breakdown of academic impact, for papers by Zhanju Liu
Rankless by CCL
2026